Jump Financial, LLC Biocryst Pharmaceuticals Inc Transaction History

Jump Financial, LLC

  • $6.93 Billion
  • Q1 2025

A detailed history of Jump Financial, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Jump Financial, LLC holds 148,849 shares of BCRX stock, worth $1.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
148,849
Previous 263,338 43.48%
Holding current value
$1.3 Million
Previous $1.98 Million 43.64%
% of portfolio
0.02%
Previous 0.05%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$7.06 - $9.39 $808,292 - $1.08 Million
-114,489 Reduced 43.48%
148,849 $1.12 Million
Q4 2024

Feb 13, 2025
SELL
$7.03 - $8.43 $59,059 - $70,820
-8,401 Reduced 3.09%
263,338 $1.98 Million
Q3 2024

Nov 14, 2024
BUY
$6.41 - $8.69 $458,564 - $621,673
71,539 Added 35.73%
271,739 $2.07 Million
Q2 2024

Aug 14, 2024
BUY
$4.13 - $6.79 $826,826 - $1.36 Million
200,200 New
200,200 $1.24 Million
Q4 2023

Oct 21, 2024
SELL
$4.98 - $6.77 $1.38 Million - $1.87 Million
-276,142 Reduced 68.2%
128,771 $771,000
Q4 2023

Feb 07, 2024
SELL
$4.98 - $6.77 $1.38 Million - $1.87 Million
-276,142 Reduced 68.2%
128,771 $771,000
Q3 2023

Oct 21, 2024
BUY
$6.71 - $7.92 $2.14 Million - $2.53 Million
319,037 Added 371.51%
404,913 $2.87 Million
Q3 2023

Nov 07, 2023
BUY
$6.71 - $7.92 $2.14 Million - $2.53 Million
319,037 Added 371.51%
404,913 $2.87 Million
Q2 2023

Oct 21, 2024
SELL
$6.96 - $8.81 $1.58 Million - $2.01 Million
-227,665 Reduced 72.61%
85,876 $604,000
Q2 2023

Aug 07, 2023
SELL
$6.96 - $8.81 $1.58 Million - $2.01 Million
-227,665 Reduced 72.61%
85,876 $604,000
Q1 2023

Oct 21, 2024
BUY
$7.94 - $11.84 $899,927 - $1.34 Million
113,341 Added 56.61%
313,541 $2.61 Million
Q1 2023

May 03, 2023
BUY
$7.94 - $11.84 $2.49 Million - $3.71 Million
313,541 New
313,541 $2.61 Million
Q1 2022

May 12, 2022
SELL
$11.56 - $19.76 $384,948 - $658,008
-33,300 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$11.18 - $15.46 $372,294 - $514,818
33,300 New
33,300 $461,000
Q2 2021

Aug 13, 2021
SELL
$9.5 - $17.24 $181,497 - $329,370
-19,105 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$7.37 - $13.61 $140,803 - $260,019
19,105 New
19,105 $194,000
Q4 2020

Feb 12, 2021
SELL
$3.37 - $8.61 $644,623 - $1.65 Million
-191,283 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$3.43 - $5.53 $656,100 - $1.06 Million
191,283 New
191,283 $657,000

Others Institutions Holding BCRX

# of Institutions
294
Shares Held
177M
Call Options Held
721K
Put Options Held
489K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.63B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email